Literature DB >> 14614079

A combinatorial network of evolutionarily conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes.

Hooman F Farhadi1, Pierre Lepage, Reza Forghani, Hana C H Friedman, Wayel Orfali, Luc Jasmin, Webb Miller, Thomas J Hudson, Alan C Peterson.   

Abstract

Myelin basic protein (MBP) is required for normal myelin compaction and is implicated in both experimental and human demyelinating diseases. In this study, as an initial step in defining the regulatory network controlling MBP transcription, we located and characterized the function of evolutionarily conserved regulatory sequences. Long-range human-mouse sequence comparison revealed over 1 kb of conserved noncoding MBP 5' flanking sequence distributed into four widely spaced modules ranging from 0.1 to 0.4 kb. We demonstrate first that a controlled strategy of transgenesis provides an effective means to assign and compare qualitative and quantitative in vivo regulatory programs. Using this strategy, single-copy reporter constructs, designed to evaluate the regulatory significance of modular and intermodular sequences, were introduced by homologous recombination into the mouse hprt (hypoxanthine-guanine phosphoribosyltransferase) locus. The proximal modules M1 and M2 confer comparatively low-level oligodendrocyte expression primarily limited to early postnatal development, whereas the upstream M3 confers high-level oligodendrocyte expression extending throughout maturity. Furthermore, constructs devoid of M3 fail to target expression to newly myelinating oligodendrocytes in the mature CNS. Mutation of putative Nkx6.2/Gtx sites within M3, although not eliminating oligodendrocyte targeting, significantly decreases transgene expression levels. High-level and continuous expression is conferred to myelinating or remyelinating Schwann cells by M4. In addition, when isolated from surrounding MBP sequences, M3 confers transient expression to Schwann cells elaborating myelin. These observations define the in vivo regulatory roles played by conserved noncoding MBP sequences and lead to a combinatorial model in which different regulatory modules are engaged during primary myelination, myelin maintenance, and remyelination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614079      PMCID: PMC6741010     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  Inflammation and remyelination in the central nervous system: a tale of two systems.

Authors:  Francesca Ruffini; Timothy E Kennedy; Jack P Antel
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

2.  A regulatory toolbox of MiniPromoters to drive selective expression in the brain.

Authors:  Elodie Portales-Casamar; Douglas J Swanson; Li Liu; Charles N de Leeuw; Kathleen G Banks; Shannan J Ho Sui; Debra L Fulton; Johar Ali; Mahsa Amirabbasi; David J Arenillas; Nazar Babyak; Sonia F Black; Russell J Bonaguro; Erich Brauer; Tara R Candido; Mauro Castellarin; Jing Chen; Ying Chen; Jason C Y Cheng; Vik Chopra; T Roderick Docking; Lisa Dreolini; Cletus A D'Souza; Erin K Flynn; Randy Glenn; Kristi Hatakka; Taryn G Hearty; Behzad Imanian; Steven Jiang; Shadi Khorasan-zadeh; Ivana Komljenovic; Stéphanie Laprise; Nancy Y Liao; Jonathan S Lim; Stuart Lithwick; Flora Liu; Jun Liu; Meifen Lu; Melissa McConechy; Andrea J McLeod; Marko Milisavljevic; Jacek Mis; Katie O'Connor; Betty Palma; Diana L Palmquist; Jean-François Schmouth; Magdalena I Swanson; Bonny Tam; Amy Ticoll; Jenna L Turner; Richard Varhol; Jenny Vermeulen; Russell F Watkins; Gary Wilson; Bibiana K Y Wong; Siaw H Wong; Tony Y T Wong; George S Yang; Athena R Ypsilanti; Steven J M Jones; Robert A Holt; Daniel Goldowitz; Wyeth W Wasserman; Elizabeth M Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-31       Impact factor: 11.205

Review 3.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

4.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

5.  Differential Sox10 genomic occupancy in myelinating glia.

Authors:  Camila Lopez-Anido; Guannan Sun; Matthias Koenning; Rajini Srinivasan; Holly A Hung; Ben Emery; Sunduz Keles; John Svaren
Journal:  Glia       Date:  2015-05-14       Impact factor: 7.452

6.  Targeted insertion of two Mthfr promoters in mice reveals temporal- and tissue-specific regulation.

Authors:  Laura Pickell; Qing Wu; Xiao-Ling Wang; Daniel Leclerc; Hana Friedman; Alan C Peterson; Rima Rozen
Journal:  Mamm Genome       Date:  2011-07-19       Impact factor: 2.957

7.  Ubiquitous expression of mRFP-1 in vivo by site-directed transgenesis.

Authors:  Ekaterina Yurchenko; Hanna Friedman; Valerie Hay; Alan Peterson; Ciriaco A Piccirillo
Journal:  Transgenic Res       Date:  2006-11-01       Impact factor: 2.788

8.  Characterization of the regulatory region of the dopa decarboxylase gene in Medaka: an in vivo green fluorescent protein reporter assay combined with a simple TA-cloning method.

Authors:  Kazuhiro E Fujimori
Journal:  Mol Biotechnol       Date:  2008-11-06       Impact factor: 2.695

9.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

10.  Integrin-mediated axoglial interactions initiate myelination in the central nervous system.

Authors:  Joana Câmara; Zhen Wang; Cristina Nunes-Fonseca; Hana C Friedman; Matthew Grove; Diane L Sherman; Noboru H Komiyama; Seth G Grant; Peter J Brophy; Alan Peterson; Charles ffrench-Constant
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.